Bristol-Myers Squibb Forecast, price target & analysts
Bristol-Myers Squibb Target price 2025 - Analyst rating & recommendation
Bristol-Myers Squibb Classifications & Recommendation:
Bristol-Myers Squibb Price Target
| Target Price | $57.21 |
| Price | $48.69 |
| Potential |
17.50%
register free of charge
|
| Number of Estimates | 19 |
|
19 Analysts have issued a price target Bristol-Myers Squibb 2026 .
The average Bristol-Myers Squibb target price is $57.21.
This is
17.50%
register free of charge
$68.00
39.66%
register free of charge
$36.00
26.06%
register free of charge
|
|
| A rating was issued by 28 analysts: 7 Analysts recommend Bristol-Myers Squibb to buy, 20 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Bristol-Myers Squibb stock has an average upside potential 2026 of
17.50%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 48.30 | 45.86 |
| 7.32% | 5.05% | |
| EBITDA Margin | 39.98% | 41.65% |
| 1.59% | 4.18% | |
| Net Margin | -18.53% | 25.04% |
| 206.46% | 235.16% |
22 Analysts have issued a sales forecast Bristol-Myers Squibb 2025 . The average Bristol-Myers Squibb sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an Bristol-Myers Squibb EBITDA forecast 2025. The average Bristol-Myers Squibb EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 Bristol-Myers Squibb Analysts have issued a net profit forecast 2025. The average Bristol-Myers Squibb net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -4.41 | 5.66 |
| 214.25% | 228.34% | |
| P/E | 8.60 | |
| EV/Sales | 3.04 |
11 Analysts have issued a Bristol-Myers Squibb forecast for earnings per share. The average Bristol-Myers Squibb EPS is
This results in the following potential growth metrics and future valuations:
Bristol-Myers Squibb...
Current Bristol-Myers Squibb Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
| Jefferies |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Apr 22 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Apr 11 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Feb 07 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Feb 04 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Apr 23 2025 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Apr 23 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Apr 22 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Apr 11 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Apr 08 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Feb 07 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Feb 04 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
